Barclays
OSTX

Barclays’s OS Therapies Inc OSTX Stock Holding History

Barclays’s Portfolio OSTX Stock Details OSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.92K Buy
+1,534
New +$2.57K ﹤0.01% 4833

Other funds holding OSTX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HFS
Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Barclays's OSTX Position: Q2 2026 in Review

Barclays opened a new position in OS Therapies Inc (OSTX) in Q2 2026: 1,534 shares worth $2.92K. The stake represents ﹤0.01% of the portfolio and ranks #4833 among its holdings.

29 funds tracked by Wall St. Rank hold OSTX as of Q2 2026.

  • Barclays held 1,534 shares of OS Therapies Inc worth $2.92K as of Q2 2026.
  • OS Therapies Inc was a new Barclays position in Q2 2026.
  • OS Therapies Inc made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4833 holding.
  • 29 funds tracked by Wall St. Rank held OS Therapies Inc as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.